NxStage Medical (NXTM) Tops Q1 EPS by 2c

NxStage Medical (NASDAQ: NXTM) reported Q1 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $79.5 million versus the consensus estimate of $77.92 million.

For earnings history and earnings-related data on NxStage Medical (NXTM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SanDisk upgraded at JPMorgan after investor day; shares climb